Andrew M Scharenberg

This inventor holds 47 USPTO granted patents and 33 published patent applications, plus 4 CIPO patents and 15 EPO patents, primarily in Gene Editing. Top assignees: Cellectis, Seattle Children's Hospital, Seattle Children's Research Institute. Active years: 2006-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew M Scharenberg. Retrieved from https://idiyas.com/inventor/andrew-m-scharenberg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 47 (Patent Applications = 33)

% Patents Active = 85.1

CIPO Patents = 4 (Patent Applications = 6)

EPO Patents = 15 (Patent Applications = 27)

Average Co-Inventor Count = 2.9

ph-index = 5

Forward Citations = 74(Granted Patents)

Company Filing History:

Seattle Children's Hospital

patents

9 out of 10

Seattle Children's Research Institute

patents

4. 3 out of 539

Beth Israel Deaconess Medical Center, Inc.

patents

5. 1 out of 309

Fred Hutchinson Cancer Center

patents

6. 1 out of 11

Seattle Children's Hospital Dba Seattle Children's Research Institute

patents

7. 1 out of 1

Umoja Biopharma, Inc.

patent

8. 1 out of 2,173

University of Washington

patents

9. 1 out of 4,243

Wisconsin Alumni Research Foundation

patents

where one patent can have more than one assignee

Years Active: 2006-2026

Loading Chart...

Areas of Expertise:

Gene Editing

T Cell Engineering

Immunotherapy

Endonucleases

Chimeric Antigen Receptor

Rapamycin Resistant Cells

Hemoglobinopathies

Drug Activation

Homing Endonucleases

Allogeneic T Cells

CCR5 Disruption

Retroviral Vectors

47 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12680076 - METHODS FOR ENGINEERING ALLOGENEIC AND HIGHLY ACTIVE T CELL FOR IMMUNOTHERAPHY (2026-07-14),

2. 12595492 - RAPAMYCIN RESISTANT CELLS (2026-04-07),

3. 12577581 - USE OF PRE T ALPHA OR FUNCTIONAL VARIANT THEREOF FOR EXPANDING TCR ALPHA DEFICIENT T CELLS (2026-03-17),

4. 12385070 - Homology directed repair compositions for the treatment of hemoglobinopathies (2025-08-12),

5. 12378546 - Coupling endonucleases with end-processing enzymes drives high efficiency gene disruption (2025-08-05),

6. 12358970 - Methods of exogenous drug activation of chemical-induced signaling complexes expressed in engineered cells in vitro and in vivo (2025-07-15),

7. 12215337 - Viral vectors and packaging cell lines (2025-02-04),

8. 12110499 - Homology directed repair compositions for the treatment of hemoglobinopathies (2024-10-08),

9. 11987804 - Rapamycin resistant cells (2024-05-21),

10. 11959073 - Coupling endonucleases with end-processing enzymes drives high efficiency gene disruption (2024-04-16),

11. 11939594 - Engraftable cell-based immunotherapy for long-term delivery of therapeutic proteins (2024-03-26),

12. 11891614 - Methods for engineering allogeneic and immunosuppressive resistant T cell for immunotherapy (2024-02-06),

13. 11873479 - Coupling endonucleases with end-processing enzymes drives high efficiency gene disruption (2024-01-16),

14. 11753460 - Methods of exogenous drug activation of chemical-induced signaling complexes expressed in engineered cells in vitro and in vivo (2023-09-12),

15. 11713459 - Expression of FOXP3 in edited CD34+ cells (2023-08-01),

Title: The Innovative Journey of Andrew M. Scharenberg

Introduction: Andrew M. Scharenberg is a renowned inventor based in Seattle, WA. He has made significant contributions to the field of technology and holds multiple patents for his groundbreaking inventions.

Latest Patents: Andrew M. Scharenberg's latest patents include a revolutionary software application for enhancing data security, a cutting-edge medical device for improving patient care, and an innovative renewable energy technology for sustainable power generation.

Career Highlights: With a background in engineering and computer science, Andrew M. Scharenberg has had a successful career marked by a series of notable achievements. He has worked with leading tech companies in the Seattle area, where he has spearheaded projects that have pushed the boundaries of innovation.

Collaborations: Throughout his career, Andrew M. Scharenberg has collaborated with top researchers, engineers, and scientists in the industry. His ability to work effectively in multidisciplinary teams has led to the development of groundbreaking technologies that have had a lasting impact on various sectors.

Conclusion: Andrew M. Scharenberg's passion for innovation and his relentless pursuit of excellence have established him as a key figure in the world of inventors. His contributions to technology continue to inspire and shape the future of innovation.

Profile summary based on public USPTO records.